カテゴリ： 世界, QYResearch, 部品/材料

レフルノミドの世界市場2023年：純度99%、純度99.5%

■ 英語タイトル：Global Leflunomide Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA1385）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA1385
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：67
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[レフルノミドの世界市場2023年：純度99%、純度99.5%]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はレフルノミドのグローバル市場について調査・分析し、世界のレフルノミド市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析（純度99%、純度99.5%）、用途別セグメント分析（関節リウマチ、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sanofi、DM Pharma、Changzhou Yabang Pharmaceuticalなどが含まれています。レフルノミドのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争による影響は、レフルノミド市場規模を算出する際に考慮しました。

・レフルノミド市場の概要
- 製品の定義
- レフルノミドの種類別セグメント
- 世界のレフルノミド市場成長率のタイプ別分析（純度99%、純度99.5%）
- レフルノミドの用途別セグメント
- 世界のレフルノミド市場成長率の用途別分析（関節リウマチ、その他）
- 世界市場の成長展望
- 世界のレフルノミド生産量の推定と予測（2018年-2029年）
- 世界のレフルノミド生産能力の推定と予測（2018年-2029年）
- レフルノミドの平均価格の推定と予測（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- レフルノミド市場の競争状況およびトレンド

・レフルノミドの地域別生産量
- レフルノミド生産量の地域別推計と予測（2018年-2029年）
- 地域別レフルノミド価格分析（2018年-2023年）
- 北米のレフルノミド生産規模（2018年-2029年）
- ヨーロッパのレフルノミド生産規模（2018年-2029年）
- 中国のレフルノミド生産規模（2018年-2029年）
- 日本のレフルノミド生産規模（2018年-2029年）
- 韓国のレフルノミド生産規模（2018年-2029年）
- インドのレフルノミド生産規模（2018年-2029年）

・レフルノミドの地域別消費量
- レフルノミド消費量の地域別推計と予測（2018年-2029年）
- 北米のレフルノミド消費量（2018年-2029年）
- 米国のレフルノミド消費量（2018年-2029年）
- ヨーロッパのレフルノミド消費量（2018年-2029年）
- アジア太平洋のレフルノミド消費量（2018年-2029年）
- 中国のレフルノミド消費量（2018年-2029年）
- 日本のレフルノミド消費量（2018年-2029年）
- 韓国のレフルノミド消費量（2018年-2029年）
- 東南アジアのレフルノミド消費量（2018年-2029年）
- インドのレフルノミド消費量（2018年-2029年）
- 中南米・中東・アフリカのレフルノミド消費量（2018年-2029年）

・種類別セグメント：純度99%、純度99.5%
- 世界のレフルノミドのタイプ別生産量（2018年-2023年）
- 世界のレフルノミドのタイプ別生産量（2024年-2029年）
- 世界のレフルノミドのタイプ別価格

・用途別セグメント：関節リウマチ、その他
- 世界のレフルノミドの用途別生産量（2018年-2023年）
- 世界のレフルノミドの用途別生産量（2024年-2029年）
- 世界のレフルノミドの用途別価格

・主要企業のプロファイル：企業情報、製品ポートフォリオ、生産量、価格、動向
Sanofi、DM Pharma、Changzhou Yabang Pharmaceutical

・産業チェーンと販売チャネルの分析
- レフルノミド産業チェーン分析
- レフルノミドの主要原材料
- レフルノミドの販売チャネル
- レフルノミドのディストリビューター
- レフルノミドの主要顧客

・レフルノミド市場ダイナミクス
- レフルノミドの業界動向
- レフルノミド市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

The global Leflunomide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Leflunomide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Leflunomide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Leflunomide include Sanofi, DM Pharma and Changzhou Yabang Pharmaceutical, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Leflunomide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leflunomide.
The Leflunomide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Leflunomide market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leflunomide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sanofi
DM Pharma
Changzhou Yabang Pharmaceutical
Segment by Type
99% Purity
99.5% Purity
Segment by Application
Rheumatoid Arthritis
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Leflunomide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Leflunomide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Leflunomide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Leflunomide Market Overview
1.1 Product Definition
1.2 Leflunomide Segment by Type
1.2.1 Global Leflunomide Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 99% Purity
1.2.3 99.5% Purity
1.3 Leflunomide Segment by Application
1.3.1 Global Leflunomide Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Rheumatoid Arthritis
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Leflunomide Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Leflunomide Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Leflunomide Production Estimates and Forecasts (2018-2029)
1.4.4 Global Leflunomide Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Leflunomide Production Market Share by Manufacturers (2018-2023)
2.2 Global Leflunomide Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Leflunomide, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Leflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Leflunomide Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Leflunomide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Leflunomide, Product Offered and Application
2.8 Global Key Manufacturers of Leflunomide, Date of Enter into This Industry
2.9 Leflunomide Market Competitive Situation and Trends
2.9.1 Leflunomide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Leflunomide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Leflunomide Production by Region
3.1 Global Leflunomide Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Leflunomide Production Value by Region (2018-2029)
3.2.1 Global Leflunomide Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Leflunomide by Region (2024-2029)
3.3 Global Leflunomide Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Leflunomide Production by Region (2018-2029)
3.4.1 Global Leflunomide Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Leflunomide by Region (2024-2029)
3.5 Global Leflunomide Market Price Analysis by Region (2018-2023)
3.6 Global Leflunomide Production and Value, Year-over-Year Growth
3.6.1 North America Leflunomide Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Leflunomide Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Leflunomide Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Leflunomide Production Value Estimates and Forecasts (2018-2029)
4 Leflunomide Consumption by Region
4.1 Global Leflunomide Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Leflunomide Consumption by Region (2018-2029)
4.2.1 Global Leflunomide Consumption by Region (2018-2023)
4.2.2 Global Leflunomide Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Leflunomide Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Leflunomide Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Leflunomide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Leflunomide Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Leflunomide Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Leflunomide Production by Type (2018-2029)
5.1.1 Global Leflunomide Production by Type (2018-2023)
5.1.2 Global Leflunomide Production by Type (2024-2029)
5.1.3 Global Leflunomide Production Market Share by Type (2018-2029)
5.2 Global Leflunomide Production Value by Type (2018-2029)
5.2.1 Global Leflunomide Production Value by Type (2018-2023)
5.2.2 Global Leflunomide Production Value by Type (2024-2029)
5.2.3 Global Leflunomide Production Value Market Share by Type (2018-2029)
5.3 Global Leflunomide Price by Type (2018-2029)
6 Segment by Application
6.1 Global Leflunomide Production by Application (2018-2029)
6.1.1 Global Leflunomide Production by Application (2018-2023)
6.1.2 Global Leflunomide Production by Application (2024-2029)
6.1.3 Global Leflunomide Production Market Share by Application (2018-2029)
6.2 Global Leflunomide Production Value by Application (2018-2029)
6.2.1 Global Leflunomide Production Value by Application (2018-2023)
6.2.2 Global Leflunomide Production Value by Application (2024-2029)
6.2.3 Global Leflunomide Production Value Market Share by Application (2018-2029)
6.3 Global Leflunomide Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Sanofi
7.1.1 Sanofi Leflunomide Corporation Information
7.1.2 Sanofi Leflunomide Product Portfolio
7.1.3 Sanofi Leflunomide Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Sanofi Main Business and Markets Served
7.1.5 Sanofi Recent Developments/Updates
7.2 DM Pharma
7.2.1 DM Pharma Leflunomide Corporation Information
7.2.2 DM Pharma Leflunomide Product Portfolio
7.2.3 DM Pharma Leflunomide Production, Value, Price and Gross Margin (2018-2023)
7.2.4 DM Pharma Main Business and Markets Served
7.2.5 DM Pharma Recent Developments/Updates
7.3 Changzhou Yabang Pharmaceutical
7.3.1 Changzhou Yabang Pharmaceutical Leflunomide Corporation Information
7.3.2 Changzhou Yabang Pharmaceutical Leflunomide Product Portfolio
7.3.3 Changzhou Yabang Pharmaceutical Leflunomide Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Changzhou Yabang Pharmaceutical Main Business and Markets Served
7.3.5 Changzhou Yabang Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Leflunomide Industry Chain Analysis
8.2 Leflunomide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Leflunomide Production Mode & Process
8.4 Leflunomide Sales and Marketing
8.4.1 Leflunomide Sales Channels
8.4.2 Leflunomide Distributors
8.5 Leflunomide Customers
9 Leflunomide Market Dynamics
9.1 Leflunomide Industry Trends
9.2 Leflunomide Market Drivers
9.3 Leflunomide Market Challenges
9.4 Leflunomide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

List of Tables
Table 1. Global Leflunomide Market Value by Type, (US$ Million) & (2022 VS 2029)
Table 2. Global Leflunomide Market Value by Application, (US$ Million) & (2022 VS 2029)
Table 3. Global Leflunomide Production Capacity (Tons) by Manufacturers in 2022
Table 4. Global Leflunomide Production by Manufacturers (2018-2023) & (Tons)
Table 5. Global Leflunomide Production Market Share by Manufacturers (2018-2023)
Table 6. Global Leflunomide Production Value by Manufacturers (2018-2023) & (US$ Million)
Table 7. Global Leflunomide Production Value Share by Manufacturers (2018-2023)
Table 8. Global Leflunomide Industry Ranking 2021 VS 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leflunomide as of 2022)
Table 10. Global Market Leflunomide Average Price by Manufacturers (US$/Ton) & (2018-2023)
Table 11. Manufacturers Leflunomide Production Sites and Area Served
Table 12. Manufacturers Leflunomide Product Types
Table 13. Global Leflunomide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Leflunomide Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Leflunomide Production Value (US$ Million) by Region (2018-2023)
Table 17. Global Leflunomide Production Value Market Share by Region (2018-2023)
Table 18. Global Leflunomide Production Value (US$ Million) Forecast by Region (2024-2029)
Table 19. Global Leflunomide Production Value Market Share Forecast by Region (2024-2029)
Table 20. Global Leflunomide Production Comparison by Region: 2018 VS 2022 VS 2029 (Tons)
Table 21. Global Leflunomide Production (Tons) by Region (2018-2023)
Table 22. Global Leflunomide Production Market Share by Region (2018-2023)
Table 23. Global Leflunomide Production (Tons) Forecast by Region (2024-2029)
Table 24. Global Leflunomide Production Market Share Forecast by Region (2024-2029)
Table 25. Global Leflunomide Market Average Price (US$/Ton) by Region (2018-2023)
Table 26. Global Leflunomide Market Average Price (US$/Ton) by Region (2024-2029)
Table 27. Global Leflunomide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (Tons)
Table 28. Global Leflunomide Consumption by Region (2018-2023) & (Tons)
Table 29. Global Leflunomide Consumption Market Share by Region (2018-2023)
Table 30. Global Leflunomide Forecasted Consumption by Region (2024-2029) & (Tons)
Table 31. Global Leflunomide Forecasted Consumption Market Share by Region (2018-2023)
Table 32. North America Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
Table 33. North America Leflunomide Consumption by Country (2018-2023) & (Tons)
Table 34. North America Leflunomide Consumption by Country (2024-2029) & (Tons)
Table 35. Europe Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
Table 36. Europe Leflunomide Consumption by Country (2018-2023) & (Tons)
Table 37. Europe Leflunomide Consumption by Country (2024-2029) & (Tons)
Table 38. Asia Pacific Leflunomide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (Tons)
Table 39. Asia Pacific Leflunomide Consumption by Region (2018-2023) & (Tons)
Table 40. Asia Pacific Leflunomide Consumption by Region (2024-2029) & (Tons)
Table 41. Latin America, Middle East & Africa Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
Table 42. Latin America, Middle East & Africa Leflunomide Consumption by Country (2018-2023) & (Tons)
Table 43. Latin America, Middle East & Africa Leflunomide Consumption by Country (2024-2029) & (Tons)
Table 44. Global Leflunomide Production (Tons) by Type (2018-2023)
Table 45. Global Leflunomide Production (Tons) by Type (2024-2029)
Table 46. Global Leflunomide Production Market Share by Type (2018-2023)
Table 47. Global Leflunomide Production Market Share by Type (2024-2029)
Table 48. Global Leflunomide Production Value (US$ Million) by Type (2018-2023)
Table 49. Global Leflunomide Production Value (US$ Million) by Type (2024-2029)
Table 50. Global Leflunomide Production Value Share by Type (2018-2023)
Table 51. Global Leflunomide Production Value Share by Type (2024-2029)
Table 52. Global Leflunomide Price (US$/Ton) by Type (2018-2023)
Table 53. Global Leflunomide Price (US$/Ton) by Type (2024-2029)
Table 54. Global Leflunomide Production (Tons) by Application (2018-2023)
Table 55. Global Leflunomide Production (Tons) by Application (2024-2029)
Table 56. Global Leflunomide Production Market Share by Application (2018-2023)
Table 57. Global Leflunomide Production Market Share by Application (2024-2029)
Table 58. Global Leflunomide Production Value (US$ Million) by Application (2018-2023)
Table 59. Global Leflunomide Production Value (US$ Million) by Application (2024-2029)
Table 60. Global Leflunomide Production Value Share by Application (2018-2023)
Table 61. Global Leflunomide Production Value Share by Application (2024-2029)
Table 62. Global Leflunomide Price (US$/Ton) by Application (2018-2023)
Table 63. Global Leflunomide Price (US$/Ton) by Application (2024-2029)
Table 64. Sanofi Leflunomide Corporation Information
Table 65. Sanofi Specification and Application
Table 66. Sanofi Leflunomide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 67. Sanofi Main Business and Markets Served
Table 68. Sanofi Recent Developments/Updates
Table 69. DM Pharma Leflunomide Corporation Information
Table 70. DM Pharma Specification and Application
Table 71. DM Pharma Leflunomide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 72. DM Pharma Main Business and Markets Served
Table 73. DM Pharma Recent Developments/Updates
Table 74. Changzhou Yabang Pharmaceutical Leflunomide Corporation Information
Table 75. Changzhou Yabang Pharmaceutical Specification and Application
Table 76. Changzhou Yabang Pharmaceutical Leflunomide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 77. Changzhou Yabang Pharmaceutical Main Business and Markets Served
Table 78. Changzhou Yabang Pharmaceutical Recent Developments/Updates
Table 79. Key Raw Materials Lists
Table 80. Raw Materials Key Suppliers Lists
Table 81. Leflunomide Distributors List
Table 82. Leflunomide Customers List
Table 83. Leflunomide Market Trends
Table 84. Leflunomide Market Drivers
Table 85. Leflunomide Market Challenges
Table 86. Leflunomide Market Restraints
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Leflunomide
Figure 2. Global Leflunomide Market Value by Type, (US$ Million) & (2022 VS 2029)
Figure 3. Global Leflunomide Market Share by Type: 2022 VS 2029
Figure 4. 99% Purity Product Picture
Figure 5. 99.5% Purity Product Picture
Figure 6. Global Leflunomide Market Value by Application, (US$ Million) & (2022 VS 2029)
Figure 7. Global Leflunomide Market Share by Application: 2022 VS 2029
Figure 8. Rheumatoid Arthritis
Figure 9. Other
Figure 10. Global Leflunomide Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Leflunomide Production Value (US$ Million) & (2018-2029)
Figure 12. Global Leflunomide Production Capacity (Tons) & (2018-2029)
Figure 13. Global Leflunomide Production (Tons) & (2018-2029)
Figure 14. Global Leflunomide Average Price (US$/Ton) & (2018-2029)
Figure 15. Leflunomide Report Years Considered
Figure 16. Leflunomide Production Share by Manufacturers in 2022
Figure 17. Leflunomide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. The Global 5 and 10 Largest Players: Market Share by Leflunomide Revenue in 2022
Figure 19. Global Leflunomide Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 20. Global Leflunomide Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 21. Global Leflunomide Production Comparison by Region: 2018 VS 2022 VS 2029 (Tons)
Figure 22. Global Leflunomide Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 23. North America Leflunomide Production Value (US$ Million) Growth Rate (2018-2029)
Figure 24. Europe Leflunomide Production Value (US$ Million) Growth Rate (2018-2029)
Figure 25. China Leflunomide Production Value (US$ Million) Growth Rate (2018-2029)
Figure 26. Japan Leflunomide Production Value (US$ Million) Growth Rate (2018-2029)
Figure 27. Global Leflunomide Consumption by Region: 2018 VS 2022 VS 2029 (Tons)
Figure 28. Global Leflunomide Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 29. North America Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 30. North America Leflunomide Consumption Market Share by Country (2018-2029)
Figure 31. Canada Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 32. U.S. Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 33. Europe Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 34. Europe Leflunomide Consumption Market Share by Country (2018-2029)
Figure 35. Germany Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 36. France Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 37. U.K. Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 38. Italy Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 39. Russia Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 40. Asia Pacific Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 41. Asia Pacific Leflunomide Consumption Market Share by Regions (2018-2029)
Figure 42. China Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 43. Japan Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 44. South Korea Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 45. China Taiwan Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 46. Southeast Asia Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 47. India Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 48. Latin America, Middle East & Africa Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 49. Latin America, Middle East & Africa Leflunomide Consumption Market Share by Country (2018-2029)
Figure 50. Mexico Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 51. Brazil Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 52. Turkey Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 53. GCC Countries Leflunomide Consumption and Growth Rate (2018-2023) & (Tons)
Figure 54. Global Production Market Share of Leflunomide by Type (2018-2029)
Figure 55. Global Production Value Market Share of Leflunomide by Type (2018-2029)
Figure 56. Global Leflunomide Price (US$/Ton) by Type (2018-2029)
Figure 57. Global Production Market Share of Leflunomide by Application (2018-2029)
Figure 58. Global Production Value Market Share of Leflunomide by Application (2018-2029)
Figure 59. Global Leflunomide Price (US$/Ton) by Application (2018-2029)
Figure 60. Leflunomide Value Chain
Figure 61. Leflunomide Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • コバルトトリス（2,2,6,6-テトラメチル-3,5-ヘプタンジオネート）の世界市場2023年：純度99%、純度99.9%、純度99.99%、純度99.999%
  • フルオロメタン（CH3F）のグローバル市場展望 2023年-2029年：純度98%、純度99%、純度99.9%、純度99.99%、純度99.999%
  • 電子用一酸化炭素（CO）の世界市場2023年：純度99.99%以上、純度99.995%以上、純度99.995%以上
  • フッ化メチル（MeF）のグローバル市場展望 2023年-2029年：純度98%、純度99%、純度99.9%、純度99.99%、純度99.999%
  • トリス（シクロペンタジエニル）プラセオジム（III）の世界市場2023年：純度95%、純度99%、純度99.999%
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA1385 )"レフルノミドの世界市場2023年：純度99%、純度99.5%" (英文：Global Leflunomide Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。